| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREP FEES | 2,700 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CAPITAL WORLD GROWTH & INCOME | 80,251 | 101,582 |
| GROWTH FUND OF AMERICA | 9,135 | 10,761 |
| TRISALUS OPERATION LIFE SCIENCES | 4,974,328 | 1,741,536 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| ENABLE INJECTIONS COMMON | 366,407 | 366,407 | 6,478,656 |
| ENABLE INJECTIONS SERIES A PREF | 892,896 | 892,896 | 3,015,339 |
| PONCE DE LEON HEALTH SERIES A | 200,000 | 200,000 | 682,009 |
| PONCE DE LEON HEALTH SERIES A - COM. | 337,000 | 794,239 | |
| PONCE DE LEON PHARMA COMMON | 5,000 | 5,000 | 255,000 |
| PONCE DE LEON PHARMA SERIES A | 210,475 | 210,475 | 513,063 |
| PRECEPTIS MEDICAL SERIES A PREF | 266,772 | 266,772 | 389,043 |
| PRECEPTIS MEDICAL SERIES B PREF | 451,363 | 451,363 | 658,238 |
| ZUREX PHARMACEUTICALS | 200,000 |
| Name of 501(c)(3) Organization | Balance Due |
|---|---|
|
PONCE DE LEON HEALTH INC |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CONSULTING | 12,000 | 12,000 | 12,000 | |
| DIRECTOR STIPEND | 1,000 | 1,000 | 1,000 | |
| FOUNDATION SOURCE MANAGEMENT | 14,903 | 14,903 | 14,903 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FLORIDA STATE TAXES | 61 | 61 | ||
| FOREIGN TAXES | 212 |